Ansun Biopharma Announces First Patient Enrolled In Phase 3 Clinical Trial Evaluating DAS181 In Hospitalized, Immunocompromised Patients With Lower Respiratory Tract Parainfluenza Virus Infection
Share This Story, Choose Your Platform!
About the Author: abadmin
Leave A Comment
You must be logged in to post a comment.